This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a malignant tumor arising from pigment-producing cells of the skin? A. ... (Read 119 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
Which of the following is a malignant tumor arising from pigment-producing cells of the skin?
 
  A. Nevus
  B. Melanoma
  C. Adenocarcinoma
  D. Lymphosarcoma

Question 2

The breasts are fixed to the chest wall by bands of fibrous tissue called __________.
 
  A. suspensory ligaments
  B. axillary lymph nodes
  C. mammary ridges
  D. none of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joanwhite

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

B

Answer to Question 2

A




rosent76

  • Member
  • Posts: 516
Reply 2 on: Jun 25, 2018
Excellent


6ana001

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library